Literature DB >> 15113637

The 2-week rule for patients with suspected breast cancer: what can be learnt by analysing policy documents?

Charles S Cornford1, Nigel Oswald.   

Abstract

The '2-week rule', introduced in the UK during 1999, represents a significant organisational change for referral of patients with suspected breast cancer. From an analysis of policy documents, a mixture of influences and agendas from different interest groups are apparent in the current working of the policy. These include political/modernisation agendas with a variety of aims including: reducing variation in care, efficient administration, reassuring patients, improving public confidence, earlier referral and lowering the threshold for referral to improve mortality figures. Specialist agendas, exemplified by the guidelines for referral under the policy but apparent in preceding specialist literature, represent an attempt to modify the working of the policy to ensure that high proportions of those women referred have breast cancer. The agendas of these interest groups are in conflict and have implications for the future development of this particular policy. Similar considerations are likely to apply more widely to other controversial health policy developments. It may be of value to identify the agendas of the groups responsible for the introduction of such policies, as well as the agendas of groups with influence on how the policy is actually implemented, and assess the areas of conflict.

Entities:  

Mesh:

Year:  2004        PMID: 15113637     DOI: 10.1016/j.healthpol.2003.07.002

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  2 in total

1.  Patient worry and concern associated with referral on the two-week suspected head and neck pathway.

Authors:  Catherine E P Rowlands; Peter James; Derek Lowe; Simon N Rogers
Journal:  Br Dent J       Date:  2022-07-05       Impact factor: 2.727

2.  The '2-week rule' for suspected breast carcinoma: a qualitative study of the views of patients and professionals.

Authors:  Charles S Cornford; Jan Harley; Nigel Oswald
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.